Are there instances where you would omit adjuvant pembrolizumab after achieving pCR with neoadjuvant treatment for localized TNBC?

Are there instances where you would omit adjuvant pembrolizumab after achieving pCR with neoadjuvant treatment for localized TNBC?

• No, I always continue with adjuvant pembro
• Sometimes - I may omit if there are tolerability concerns during neoadjuvant therapy (beyond IRAEs requiring pembro discontinuation)
• Sometimes - I may omit for other reasons (please specify)
• Yes, I would always omit adjuvant pembrolizumab if patient achieves pCR with neoadjuvant therapy
• Other